Skip to main content

Smith & Nephew (SN) Receives a Hold from Barclays

Tipranks - Tipranks - Fri Jan 23, 5:20AM CST

Barclays analyst Hassan Al-Wakeel maintained a Hold rating on Smith & Nephew on January 20 and set a price target of £12.90.

Claim 50% Off TipRanks Premium

Al-Wakeel covers the Healthcare sector, focusing on stocks such as Smith & Nephew, Straumann Holding AG, and Koninklijke Philips N.V.. According to TipRanks, Al-Wakeel has an average return of 0.5% and a 50.00% success rate on recommended stocks.

Currently, the analyst consensus on Smith & Nephew is a Moderate Buy with an average price target of p1,465.50.

See the top stocks recommended by analysts >>

Based on Smith & Nephew’s latest earnings release for the quarter ending June 30, the company reported a quarterly revenue of p2.99 billion and a net profit of p295.65 million. In comparison, last year the company earned a revenue of p2.83 billion and had a net profit of p214 million

Based on the recent corporate insider activity of 73 insiders, corporate insider sentiment is positive on the stock. This means that over the past quarter there has been an increase of insiders buying their shares of SN in relation to earlier this year.

Read More on GB:SN:

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

All market data (will open in new tab) is provided by Barchart Solutions. Copyright © 2026.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. For exchange delays and terms of use, please read disclaimer (will open in new tab).